MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 214 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.87 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $965,178 | -18.1% | 6,609 | +29.6% | 0.00% | 0.0% |
| Q2 2023 | $1,178,100 | -87.9% | 5,100 | -87.3% | 0.00% | -85.7% |
| Q1 2023 | $9,710,750 | -66.8% | 40,084 | -60.2% | 0.02% | -53.3% |
| Q4 2022 | $29,228,175 | +281.6% | 100,700 | +64.7% | 0.04% | +400.0% |
| Q1 2019 | $7,660,000 | +7.6% | 61,149 | -3.2% | 0.01% | 0.0% |
| Q4 2018 | $7,120,000 | -45.5% | 63,169 | +3.6% | 0.01% | -43.8% |
| Q3 2018 | $13,062,000 | +22420.7% | 61,000 | +9582.5% | 0.02% | – |
| Q4 2017 | $58,000 | – | 630 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthCor Management, L.P. | 902,601 | $100,342,000 | 3.87% |
| L1 Capital Pty Ltd | 113,464 | $12,608,000 | 2.35% |
| Avoro Capital Advisors LLC | 1,225,000 | $136,183,000 | 2.34% |
| Tao Capital Management LP | 51,396 | $5,714,000 | 1.40% |
| ARMISTICE CAPITAL, LLC | 316,000 | $35,130,000 | 1.20% |
| ACUTA CAPITAL PARTNERS, LLC | 32,500 | $3,613,000 | 0.98% |
| Capital Impact Advisors, LLC | 24,351 | $2,707,000 | 0.66% |
| Baker Brothers Advisors | 1,499,213 | $166,668,000 | 0.63% |
| Rock Springs Capital Management LP | 256,768 | $28,545,000 | 0.60% |
| SHIKIAR ASSET MANAGEMENT INC | 12,000 | $1,334,000 | 0.48% |